SCHEMBL7226743

SCHEMBL7226743

CCOC(=O)Cc1ccc(N)cc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.50
CYP3A4 P08684 2/20 0.50
TSHR P16473 2/20 0.50
RECQL P46063 1/20 0.50
MAPK1 P28482 3/20 0.46
ALOX15 P16050 2/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
TDP1 Q9NUW8 3/20 0.45
CYP1A2 P05177 1/20 0.44
PDGFRB P09619 1/20 0.44
FGFR1 P11362 1/20 0.44
PDGFRA P16234 1/20 0.44
FLT1 P17948 1/20 0.44
FGFR3 P22607 1/20 0.44
KDR P35968 1/20 0.44
NPC1 O15118 1/20 0.44
LMNA P02545 4/20 0.43
MAPT P10636 4/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14436163 0.88 ALDH1A1 (0.51) ALDH1A1CYP3A4TSHRRECQLMAPK1
SCHEMBL13400411 0.86 TSHR (0.49) ALDH1A1CYP3A4TSHRMAPK1TDP1
SCHEMBL5957215 0.86 PDGFRB (0.56) ALDH1A1CYP3A4TSHRRECQLMAPK1
SCHEMBL492505 0.84 CYP1A2 (0.64) ALDH1A1TSHRMAPK1L3MBTL1TDP1
SCHEMBL5201986 0.84 LMNA (0.49) ALDH1A1MAPK1L3MBTL1TDP1CYP1A2
SCHEMBL1695161 0.84 EGFR (0.48) ALDH1A1MAPK1TDP1CYP1A2PDGFRB
SCHEMBL17675673 0.83 MAPT (0.53) ALDH1A1MAPK1TDP1CYP1A2PDGFRB
SCHEMBL5917471 0.83 CYP1A2 (0.44) ALDH1A1CYP3A4MAPK1TDP1CYP1A2
SCHEMBL397593 0.83 MEN1 (0.47) ALDH1A1MAPK1L3MBTL1TDP1CYP1A2
SCHEMBL7052691 0.82 LMNA (0.64) ALDH1A1MAPK1PDGFRBFGFR1PDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545035-B1 Having effect on various kinases and cycline/CDK complexes and on the proliferation of various tumour cells. BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-04-08 US disclosed
US-6319918-B1 FOR LYMPHOMA OR SOLID TUMORS TREATMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-20 US disclosed